Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 2 weeks ago
84 views
Shared 3 weeks ago
154 views
Shared 1 month ago
122 views
Shared 2 months ago
226 views
Regeneron and SocietyforScience
Shared 2 months ago
391 views
Regeneron and SocietyforScience
Shared 2 months ago
2.4K views
Regeneron and SocietyforScience
Shared 2 months ago
738 views
Regeneron and SocietyforScience
Shared 2 months ago
2.4K views
Regeneron and SocietyforScience
Shared 2 months ago
839 views
Shared 4 months ago
473K views
Regeneron and SocietyforScience
Shared 4 months ago
1.9K views
Shared 4 months ago
185 views
Shared 4 months ago
75 views
Shared 5 months ago
316 views
Shared 5 months ago
847 views
Shared 6 months ago
362 views
Shared 7 months ago
389 views
Shared 7 months ago
144 views
Shared 7 months ago
41K views
Shared 7 months ago
265 views
Shared 8 months ago
103K views
Shared 11 months ago
760 views
Shared 11 months ago
152 views
Shared 11 months ago
219 views
Shared 1 year ago
444 views
Shared 1 year ago
18K views
Shared 1 year ago
23K views
Shared 1 year ago
321 views
Shared 1 year ago
639 views
Shared 1 year ago
452 views
Shared 1 year ago
324 views
Shared 1 year ago
359 views
Shared 1 year ago
431 views
Shared 1 year ago
442 views